Xeris Biopharma (XERS) Financials: Revenue & Earnings
XERS$16.80—
Market cap$3.10BEnterprise value—Revenue (TTM)$368.26MMarket position—
Score
65
Bullish
Value
32
Quality
70
Growth
94
Financial Summary
Xeris Biopharma Holdings, Inc. (XERS) last printed $16.80. Equity value is $3.10B. Trailing earnings multiple —. The revenue row is reported history.
Financials
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| $1.07M | $1.56M | $2.46M | $2.72M | $20.43M | $49.59M | $110.25M | $163.91M | $203.07M | $291.85M |